Correction: Adipose stem cells from type 2 diabetic mice exhibit therapeutic potential in wound healing

Correction to: Stem Cell Research & Therapy (2020) 11:298 https://doi.org/10.1186/s13287-020-01817-1

The authors regret that they identified inadvertent errors during manuscript preparation that incorrect photos have been mis-uploaded in Fig. 3. Corrections made are listed below.

Figure 3B: The flow cytometry sub-figures in the low panels were duplicates of the upper panel instead of correct figures from the T2D group. It has now been replaced with the right sub-figures.

Figure 3D: C57BL/6 Adipogenesis (upper panel, left): A figure from the T2D group was mistakenly uploaded and is now corrected.

Figure 3D: Chondrogenesis: C57BL/6 and T2D subfigures were misplaced, and now corrected.

Fig. 3

Characterization of ASCs isolated from C57BL/6 and T2D mice. a Representative micrographs of C57BL/6 and T2D ASCs at passage 0 and passage 3 observed under a light microscope. b Expression of CD29, CD105, CD34, and CD45 in ASCs harvested from C57BL/6L or T2D mice analyzed by flow cytometry. c Growth curves of C57BL/6 and T2D ASCs at passage 3. d The morphology of adipocytes, osteocytes, and chondrocytes derived from C57BL/6 ASCs and T2D ASCs identified by Oil Red, Alizarin Red, and Alcian Blue staining, respectively. Scale bar = 100 μm. e Concentrations of VEGF, HGF, and TGF-β secreted by C57BL/6 ASCs or T2D ASCs. Data are mean ± SEM of at least three individual experiments. At least 3 mice were included in each group. *P < 0.05, **P < 0.01, ANOVA test